Lianyungang, China

Huihui Zhang

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Huihui Zhang: Innovator in Syk Inhibition

Introduction

Huihui Zhang is a notable inventor based in Lianyungang, China. With a focus on pharmaceutical innovations, he holds a significant patent that contributes to advancements in medical science.

Latest Patents

Huihui Zhang has been awarded one patent titled "Salt of Syk Inhibitor and Crystalline Form Thereof." This patent provides a detailed description of a salt of an Syk inhibitor, particularly focusing on the compound 5-fluoro-1-methyl-3-((5-(4-(oxetan-3-yl)piperazine-1)-yl)pyridin-2-yl)amino)-6-(1H-pyrazol-3-yl)quinoline-2(1H)-ketamine hydrochloride. The patent highlights the crystalline form of this compound, its preparation method, and its pharmaceutical applications. Notably, the hydrochloride of this compound displays excellent salt-forming properties, high stability, and low hygroscopicity, making it advantageous for medicinal preparations.

Career Highlights

Huihui Zhang currently works with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a prominent company in the pharmaceutical sector. His contributions to the field have been instrumental in developing new therapeutics that enhance patient care and safety.

Collaborations

Throughout his career, Huihui has collaborated with fellow researcher Wenyuan Qian. Their partnership underscores the importance of teamwork in driving innovation within the pharmaceutical industry.

Conclusion

Huihui Zhang exemplifies the spirit of innovation within the pharmaceutical field. His patent on the Syk inhibitor is a testament to his dedication to improving healthcare through scientific advancements. As the demand for effective medications continues to grow, Zhang's contributions are sure to play a pivotal role in the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…